Please select a Capability in order to start your service request.
Obtain diagnostic accuracy through precision product design and a commitment to reliability
The BD Viper™ system with XTR technology is a single automated platform that efficiently runs five sexually transmitted disease assays with clinical accuracy and minimal hands-on time.
BD has implemented a broad range of measures to provide you with the most reliable test results to serve your patients' needs.
Fast, actionable results
The system requires a 10-minute setup time only, and provides clear yes/no results―no equivocal zone.
Safe waste management
Liquid waste is automatically neutralized and collected in a waste bottle. Pipette tips are automatically discarded and collected in waste box.
Continuous batching, batch size 96 specimens two hours and 40 minutes for the first 184 CT/GC results; 184 CT/GC results every one hour and 40 minutes following the first results.
Amplification and detection technology
The system features strand displacement amplification with real-time amplification and detection. Closed solid barrier amplification system.
The system features an onboard capacity of 96 samples including controls per run and six-station pipettor with liquid-level sensing. A membrane switch pad records the location of the tube.
Specimen collection type
Vaginal and endocervical swabs, urethral swabs, urine, liquid-based cytology (LBC). All collection devices utilize pierceable caps during processing.
BD ProbeTec™ Qx amplified STI DNA assays provide accurate and relevant clinical answers for your patients. With the BD Viper system in Extracted mode, it uses strand displacement amplification technology for direct, qualitative detection.
|BD ProbeTec assays available for BD Viper XTR system|
|441126||BD ProbeTec™ CT assay||Neisseria gonorrhoeae DNA in clinician-collected female endocervical and male urethral swab specimens, patient-collected vaginal swab specimens (in a clinical setting), and male and female urine specimens|
|441124||BD ProbeTec™ GC assay||Chlamydia trachomatis DNA in clinician-collected female endocervical and male urethral swab specimens, patient-collected vaginal swab specimens (in a clinical setting), and male and female urine specimens|
|441749||BD ProbeTec™ HSV 1 and 2 assay||Detection and differentiation of herpes simplex virus type 1 (HSV1) and herpes simplex virus type 2 (HSV2) DNA in clinician-collected external anogenital lesion specimens|
|441917||BD ProbeTec™ TV assay||Trichomonas vaginalis DNA in clinician-collected female endocervical swab specimens, patient-collected vaginal swab specimens (in a clinical setting), and female urine specimens|